Health Condition 1: B- Imaging
Conditions
Interventions
Intervention1: intranasal dexmeditomidine: Group D: Intranasal Dexmeditomidine
3 microgram/kg dexmedetomidine
Drug will be taken undiluted in 1ml insulin syringe. Equal volume of drug to be insti
Sponsors
Medical College Baroda
Eligibility
Inclusion criteria
Inclusion criteria: 1.Pediatrics age group(6months to 8years) 2.either sex 3.ASA grade I ,II,III 4.Children whose guardians have given consent for procedure 5.MRI scaning time less than 60 minute
Exclusion criteria
Exclusion criteria: 1.Known case of hypersensitive reaction to drug in study. 2.Presence of congenital heart disease,pulmonary disease. 3.Recent upper respiratory infection or pneumonia. 4.Facial malformation and anticipatory difficult airway may require tracheal intubation . 5.Nasal malformation including polyps,CSF rhinorrea ,nasal bone fracture,epitaxis etc . 6.Extreme tonsillar hypertropy. 7.Previous history of prolong sedation may requiring assisted airway manipulation or active airway intervention. 8.Head trauma ,increased intracranial tension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare quality of sedationTimepoint: BASELINE | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Hemodynamic parameter 2)quality of MRI scanning 3)observed side effect and complication following sedation 4)post procedure discharge scaleTimepoint: starting point to discharge from recovery room | — |
Countries
India
Contacts
Public ContactDr NOOTAN MARU
Goverment medical college Baroda
Outcome results
None listed